Sentynl completes asset transfer of CUTX-101 Copper Histidinate product candidate for treatment of Menkes Disease from Cyprium Read more
Copper Histidinate data to be presented at 2022 American College of Medical Genetics Annual Clinical Genetics Meeting Read more